RayzeBio

Front Page

United States · $418.0M raised

Business Model
B2B
Total Funding
$418.0M
Last Round
$108.0M Series CSep 2022
Rounds
4

About

RayzeBio, a Bristol Myers Squibb company, develops targeted radiopharmaceutical therapies for people living with cancer. The company combines drug discovery, development, manufacturing, and clinical work around radioisotope-based medicines designed to deliver radiation precisely to cancer cells. Its San Diego research facility supports the discovery of novel radiopharmaceutical candidates, while its pipeline advances therapies through clinical development with the aim of expanding treatment options for patients.

Summary

RayzeBio is a Biotech company based in United States. It has raised $418.0M in total across 4 rounds, most recently a $108.0M Series C round in Sep 2022. Investors include venBIO Partners, Versant Ventures and Venrock.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series CSeries CSep 2022
$108.0M

Sign up to see all 4 rounds

Series A through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

RayzeBio on Indexed.vc
<a href="https://indexed.vc/companies/rayzebio"><img src="https://indexed.vc/api/badge/company/rayzebio" alt="RayzeBio on Indexed.vc" width="260" height="76" /></a>